David Hall's most recent trade in ITeos Therapeutics Inc was a trade of 38,228 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,228 | 0 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 04 Jun 2025 | 38,228 | 0 | - | 10.2 | 391,455 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,228 | 38,228 | - | 4.3 | 164,380 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,227 | 38,227 | - | 4.3 | 164,376 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,227 | 38,228 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,227 | 76,455 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 04 Jun 2025 | 38,227 | 0 | - | 10.1 | 388,004 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,227 | 38,227 | - | 4.3 | 164,376 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 04 Jun 2025 | 38,227 | 0 | - | 10.1 | 384,946 | Common Stock |
| Scholar Rock Holding Corp | David L. Hallal | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 275,167 | 275,167 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 1,250,000 | 1,804,095 (6%) | 4% | 0 | Common Stock | |
| Scholar Rock Holding Corp | David L. Hallal | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 250,000 | 554,095 (1%) | 0% | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 304,095 (1%) | 0% | 0 | Common Stock | |
| Seer Inc - Ordinary Shares... | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 58,178 | 355,128 | - | 0 | Class A Common Stock | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David L. Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 2,143,662 | - | 0 | Common Stock | |
| Scholar Rock Holding Corp | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 22,383 | 22,383 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 2,108,662 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.35 per share. | 29 Sep 2022 | 400,000 | 720,965 | - | 7.4 | 2,940,920 | Common Stock |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.61 per share. | 28 Jul 2022 | 3,253,796 | 16,674,766 | - | 4.6 | 15,000,000 | Common Stock |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.33 per share. | 21 Jul 2022 | 4,227 | 2,073,662 | - | 5.3 | 22,528 | Common Stock |
| Scholar Rock Holding Corp | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Seer Inc - Ordinary Shares... | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 29,640 | 29,640 | - | - | Stock Option (right to buy) | |
| Seer Inc - Ordinary Shares... | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 9,945 | 273,507 | - | 0 | Class A Common Stock | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.67 per share. | 03 Jun 2022 | 65,725 | 2,077,889 | - | 3.7 | 241,106 | Common Stock |
| Scholar Rock Holding Corp | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.87 per share. | 21 Apr 2022 | 4,227 | 2,143,614 | - | 5.9 | 24,812 | Common Stock |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,115 | 0 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,115 | 5,516 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 946 | 4,755 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 946 | 2,836 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.00 per share. | 19 Feb 2022 | 417 | 5,099 (0%) | 0% | 121 | 50,457 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.00 per share. | 19 Feb 2022 | 354 | 4,401 (0%) | 0% | 121 | 42,834 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 732 | 731 | - | - | Performance Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 732 | 4,082 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 725 | 3,660 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 725 | 1,450 | - | - | Performance Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.41 per share. | 14 Feb 2022 | 310 | 3,350 (0%) | 0% | 119.4 | 37,017 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.60 per share. | 14 Feb 2022 | 273 | 3,809 (0%) | 0% | 119.6 | 32,651 | Common Shares |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 24 Jan 2022 | 17,100 | 2,213,566 | - | 8.0 | 136,889 | Common Stock |
| ITeos Therapeutics Inc | David Hallal | Director | Sale of securities on an exchange or to another person at price $ 43.57 per share. | 20 Dec 2021 | 50,000 | 0 | - | 43.6 | 2,178,500 | Common Stock |
| ITeos Therapeutics Inc | David Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 30,000 | 37,039 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. | 20 Dec 2021 | 30,000 | 50,000 | - | 3.0 | 88,500 | Common Stock |
| ITeos Therapeutics Inc | David Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Dec 2021 | 20,000 | 20,000 | - | 4.3 | 86,000 | Common Stock |
| ITeos Therapeutics Inc | David Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 20,000 | 114,682 | - | - | Stock Option (Right to Buy) | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Sale of securities on an exchange or to another person at price $ 126.00 per share. | 11 Aug 2021 | 12,626 | 2,935 (0%) | 0% | 126 | 1,590,876 | Common Shares |
| ITeos Therapeutics Inc | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 16,608 | 16,608 | - | - | Stock Option (Right to Buy) | |
| Seer Inc - Ordinary Shares... | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Scholar Rock Holding Corp | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 1,284 | 0 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 1,284 | 17,490 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.63 per share. | 24 Feb 2021 | 313 | 17,177 (0%) | 0% | 98.6 | 30,871 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 3,782 | 3,782 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 3,782 | 3,782 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,232 | 15,908 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 2,232 | 0 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,114 | 1,115 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,114 | 16,478 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.80 per share. | 19 Feb 2021 | 544 | 15,364 (0%) | 0% | 99.8 | 54,291 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.80 per share. | 19 Feb 2021 | 272 | 16,206 (0%) | 0% | 99.8 | 27,146 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2021 | 732 | 1,463 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2021 | 732 | 13,868 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2021 | 725 | 2,175 | - | - | Restricted Share Units | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2021 | 725 | 13,351 (0%) | 0% | 0 | Common Shares | |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.36 per share. | 14 Feb 2021 | 215 | 13,136 (0%) | 0% | 99.4 | 21,362 | Common Shares |
| Waste Connections Inc | David M. Hall | Sr. Vice President - Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.36 per share. | 14 Feb 2021 | 192 | 13,676 (0%) | 0% | 99.4 | 19,077 | Common Shares |
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 273,000 | 273,000 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 147,000 | 2,230,666 | - | 0 | Common Stock | |
| PC Connection, Inc. | David Hall | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 500 | 25,868 (0%) | 0% | 0 | Common Stock | |
| PC Connection, Inc. | David Hall | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 500 | 0 | - | - | Restricted Stock Units | |
| PC Connection, Inc. | David Hall | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 500 | 25,368 (0%) | 0% | 0 | Common Stock | |
| PC Connection, Inc. | David Hall | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 500 | 3,500 | - | - | Restricted Stock Units | |
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 20,000,000 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 13,420,970 | 13,420,970 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 1,100,000 | 0 | - | - | Series A-4 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 738,153 | 738,153 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 233,333 | 0 | - | - | Series A-4 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | 03 Aug 2020 | 156,577 | 1,120,965 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | David Hallal | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 1,101,000 | 1,101,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 16,608 | 0 | - | - | Stock Option (Right to Buy) |